Join the DDA or

Olopatadine USV 1mg/mL eye drops recall

Precautionary measure

April 12th 2022

Tagged: MHRA alert

By MHRA

USV UK Limited is recalling five batches of olopatadine USV 1mg/mL eye drops (olopatadine hydrochloride) solution.

The affected batches are:

Batch numberExpiry datePack sizeFirst distributed
3500020107/20235ML14 July 2021
3500020207/20235ML27 July 2021
3500020307/20235ML5 August 2021
3500020407/20235ML29 November 2021
3500020607/20235ML23 July 2021

The recall is a precautionary measure due to out of specification results for impurities during routine stability testing. The company’s investigation is on-going.

Healthcare professionals are asked to quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

No reports of adverse reactions related to the issue above have been received. 

For more information, medical or supply enquiries, please contact [email protected]